Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05514444 |
| Title | Study of MK-4464 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced/Metastatic Solid Tumors (MK-4464-001) |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Merck Sharp & Dohme LLC |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | NLD | ISR | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| The University of Louisville, James Graham Brown Cancer Center ( Site 0100) | Louisville | Kentucky | 40245 | United States | Details | |
| Princess Margaret Cancer Centre-Division of Medical Oncology and Hematology ( Site 0201) | Toronto | Ontario | M5G 2M9 | Canada | Details | |
| Rambam Health Care Campus-Oncology Division ( Site 0300) | Haifa | 3109601 | Israel | Details | ||
| Hadassah Medical Center-Oncology ( Site 0302) | Jerusalem | 9112001 | Israel | Details | ||
| Nederlands Kanker Instituut - Antoni van Leeuwenhoek - NKI-AVL ( Site 0401) | Amsterdam | Noord-Holland | 1066CX | Netherlands | Details | |
| Amsterdam UMC, locatie VUmc ( Site 0400) | Amsterdam | Noord-Holland | 1081HV | Netherlands | Details |